(Q37868002)

24 August 2017

1 reference

title

Drug-induced lupus erythematosus: incidence, management and prevention (English)

1 reference

drug-induced lupus erythematosus

24 August 2017

1 reference

1 reference

2

M Eric Gershwin

1 reference

24 August 2017

Christopher Chang

1

1 reference

24 August 2017

publication date

1 May 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

34

1 reference

24 August 2017

issue

5

1 reference

24 August 2017

page(s)

357-374

1 reference

Drugs and autoimmunity--a contemporary review and mechanistic approach

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Effects of tobacco smoke on immunity, inflammation and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

The geoepidemiology of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

The immune effects of naturally occurring and synthetic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Nutrition, geoepidemiology, and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Hepatitis C and interferon induced thyroiditis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Geo-epidemiology and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Terbinafine-induced subacute cutaneous lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Chronic cutaneous lupus flare induced by systemic 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Serologic Evaluation of Patients Receiving Procainamide

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Hydrallazine-induced cutaneous vasculitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Minocycline and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Minocycline-induced lupus. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Autoimmunity and minocycline

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Minocycline-induced lupus: clinical features and response to rechallenge

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Infection, vaccines and other environmental triggers of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Mercury and silver induce B cell activation and anti-nucleolar autoantibody production in outbred mouse stocks: are environmental factors more important than the susceptibility genes in connection with autoimmunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Acrylamine-induced autoimmune phenomena

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

21 January 2018

Anti-TNF-induced lupus

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Drug-induced lupus due to anti-tumor necrosis factor alpha agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Treatment with tumour necrosis factor alpha antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Lessons for lupus from tumour necrosis factor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Prognostic significance of autoimmunity during treatment of melanoma with interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Autoimmunity caused by disruption of central T cell tolerance. A murine model of drug-induced lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Disruption of positive selection of thymocytes causes autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Quinidine and procainamide inhibit murine macrophage uptake of apoptotic and necrotic cells: a novel contributing mechanism of drug-induced-lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Chlorpromazine induces apoptosis in activated human lymphoblasts: a mechanism supporting the induction of drug-induced lupus erythematosus?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

DNA methylation and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupuslike disease in syngeneic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Decreased T cell ERK pathway signaling may contribute to the development of lupus through effects on DNA methylation and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

DNA methylation in T cells from idiopathic lupus and drug-induced lupus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Systemic lupus erythematosus and apoptosis: a question of balance

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Apoptosis in different cutaneous manifestations of lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Inhibition of Hydroxymethylglutaryl-Coenzyme A Reductase Reduces Th1 Development and Promotes Th2 Development

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

D-penicillamine-induced autoimmunity: relationship to macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Multiple effects of cyclosporin A on the thymus in relation to T-cell development and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence for a possible association with infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Development of lupus‐related side‐effects in patients with early RA during sulphasalazine treatment—the role of IL‐10 and HLA

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Autoimmune Diseases Induced by TNF-Targeted Therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588500-000000000-00000

Current trends in drug-induced autoimmunity

21 January 2018

1 reference

12 December 2020

A complex epitope: comment on the article by Mongey et al

1 reference

12 December 2020

Studies on the control of hypertension by hyphex. II. Toxic reactions and side effects

1 reference

12 December 2020

Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents.

1 reference

12 December 2020

Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells

1 reference

12 December 2020

Chronic inflammatory arthritis after treatment with high-dose interleukin-2 for malignancy

1 reference

12 December 2020

1 reference

12 December 2020

Lupus erythematosus-like syndrome complicating hydralazine (apresoline) therapy

1 reference

12 December 2020

Impaired T cell protein kinase C delta activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus

1 reference

12 December 2020

Joint pain with aromatase inhibitors: abnormal frequency of Sjögren's syndrome.

1 reference

12 December 2020

Procainamide induced lupus erythematosus syndrome

1 reference

12 December 2020

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

1 reference

12 December 2020

Two distinct quinidine-induced rheumatic syndromes

1 reference

12 December 2020

Antihistone antibody profile in sulfasalazine induced lupus

1 reference

12 December 2020

Drug-induced subacute cutaneous lupus erythematosus resulting from ticlopidine

1 reference

12 December 2020

Autoantibodies profile of rheumatoid arthritis patients during treatment with infliximab

1 reference

12 December 2020

Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors

1 reference

12 December 2020

Two cases of late-onset drug-induced lupus erythematosus caused by ticlopidine in elderly men.

1 reference

12 December 2020

1 reference

12 December 2020

The environment, geo-epidemiology, and autoimmune disease: Rheumatoid arthritis

1 reference

12 December 2020

Penicillamine and the SLE syndrome

1 reference

12 December 2020

Susceptibility to cyclosporin A-induced autoimmunity: strain differences in relation to autoregulatory T cells

1 reference

12 December 2020

Proliferative lupus nephritis and leukocytoclastic vasculitis during treatment with etanercept

1 reference

12 December 2020

Chlorpromazine-induced lupus anticoagulant and associated immunologic abnormalities

1 reference

12 December 2020

Minocycline-related lupus

1 reference

12 December 2020

Hydralazine-induced autoimmune disease: comparison to idiopathic lupus and ANCA-positive vasculitis

1 reference

12 December 2020

Procainamide-induced lupus erythematosus

1 reference

12 December 2020

Initiation of autoimmunity by a reactive metabolite of a lupus-inducing drug in the thymus

1 reference

12 December 2020

Drug-induced vasculitis

1 reference

12 December 2020

Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome

1 reference

12 December 2020

Environmentally induced autoimmune diseases: potential mechanisms

1 reference

12 December 2020

Disseminated lupus erythematosus versus drug reaction; report of a case receiving chlorpromazine

1 reference

12 December 2020

10.2165/11588500-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

24 August 2017

1048858315

0 references

1 reference